Measuring competitive exclusion in non-small cell lung cancer
N. Farrokhian, J. Maltas, M. Dinh, A. Durmaz, P. Ellsworth, M. Hitomi, E. McClure, A. Marusyk, A. Kaznatcheev, J. G. Scott
This study measures frequency-dependent interactions between gefitinib-resistant and sensitive NSCLC populations to show that competitive exclusion depends on growth rate data, not just cost of resistance.
bioRxiv · Sep 18, 2020Cancer Biology